Evidence map›Paper›PMID 41300183›Full record

ArticleBrain sciences2025

Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database.

Stefania Chiappini, Laura Orsolini, John Martin Corkery, Amira Guirguis, Alessio Mosca, Davide Arillotta, Giovanni Martinotti, Fabrizio Schifano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stefania ChiappiniSchool of Medicine, UniCamillus University, Via di S. Alessandro 8, 00131 Rome, Italy.ORCID 0000-0002-6810-1540
Laura OrsoliniUnit of Clinical Psychiatry, Department of Experimental and Clinical Medicine (DIMSC), Faculty of Medicine and Surgery, Polytechnic University of Marche, 60126 Ancona, Italy.ORCID 0000-0002-6882-3770
John Martin CorkeryPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, Hertfordshire Medical School, University of Hertfordshire, Hatfield AL10 9AB, UK.ORCID 0000-0002-3849-817X
Amira GuirguisPharmacy, Medical School, Swansea University, Swansea SA2 8PP, UK.ORCID 0000-0001-8255-0660
Alessio MoscaDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, 66100 Chieti, Italy.ORCID 0000-0003-3832-1398
Davide ArillottaDepartment of Neurosciences, Psychology, Drug Research, and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50121 Florence, Italy.ORCID 0000-0002-8843-0595
Giovanni MartinottiDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, 66100 Chieti, Italy.ORCID 0000-0002-7292-2341
Fabrizio SchifanoPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, Hertfordshire Medical School, University of Hertfordshire, Hatfield AL10 9AB, UK.ORCID 0000-0002-4178-5401

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

buprenorphineeye disordersFAERSmethadoneopioidspharmacovigilance

Identifiers

PMID41300183
PMCPMC12650041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.